Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing drugs for orphan oncology indications, including OT-101 (antisense against TGF-β2), CA4P (vascular disrupting agent), OXi4503, and AL-101 (intranasal apomorphine for Parkinson's Disease, erectile dysfunction, and female sexual dysfunction). The company operates through subsidiaries PointR Data, Pet2DAO, and EdgePoint AI, and conducts joint venture activities through GMP Biotechnology Limited for cancer and COVID-19 therapeutics, while also pursuing AI technologies for clinical development and manufacturing.
Q2 FY2026 — expected 2026-08-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-15 | 2024-12-31 | 0001641172-25-004846 | EDGAR | 82K words |
| 2024-04-12 | 2023-12-31 | 0001493152-24-014475 | EDGAR | 85K words |
| 2023-04-14 | 2022-12-31 | 0001493152-23-012352 | EDGAR | 91K words |
| 2022-04-15 | 2021-12-31 | 0001493152-22-010094 | EDGAR | — |
| 2021-04-15 | 2020-12-31 | 0001493152-21-008920 | EDGAR | — |
| 2020-05-14 | 2019-12-31 | 0001493152-20-008845 | EDGAR | — |
| 2019-04-10 | 2018-12-31 | 0001193125-19-102832 | EDGAR | — |
| 2018-04-17 | 2017-12-31 | 0001193125-18-119206 | EDGAR | — |
| 2017-03-30 | 2016-12-31 | 0001193125-17-103621 | EDGAR | — |
| 2016-03-25 | 2015-12-31 | 0001193125-16-518083 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001493152-26-037857 | EDGAR | 45K words |
| 2025-11-17 | 2025-09-30 | 0001493152-25-023834 | EDGAR | 36K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023568 | EDGAR | 36K words |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010984 | EDGAR | 32K words |
| 2024-11-19 | 2024-09-30 | 0001493152-24-046867 | EDGAR | 37K words |
| 2024-08-14 | 2024-06-30 | 0001493152-24-031995 | EDGAR | 36K words |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019332 | EDGAR | 35K words |
| 2023-11-14 | 2023-09-30 | 0001493152-23-040804 | EDGAR | 38K words |
| 2023-08-18 | 2023-06-30 | 0001493152-23-029461 | EDGAR | 36K words |
| 2023-05-22 | 2023-03-31 | 0001493152-23-018430 | EDGAR | 34K words |
| 2022-11-18 | 2022-09-30 | 0001493152-22-032950 | EDGAR | — |
| 2022-08-22 | 2022-06-30 | 0001493152-22-023658 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0001493152-26-035999 | EDGAR | 23K words |
| 2026-07-14 | 0001493152-26-033172 | EDGAR | 1K words |
| 2026-07-14 | 0001493152-26-033171 | EDGAR | 4K words |
| 2026-04-02 | 0001493152-26-014831 | EDGAR | 12K words |
| 2026-03-30 | 0001493152-26-013503 | EDGAR | 1K words |
| 2026-03-30 | 0001493152-26-013391 | EDGAR | 1K words |
| 2026-01-29 | 0001493152-26-004237 | EDGAR | 24K words |
| 2026-01-26 | 0001493152-26-003606 | EDGAR | 4K words |
| 2026-01-07 | 0001493152-26-000821 | EDGAR | 1K words |
| 2026-01-06 | 0001493152-26-000619 | EDGAR | 1K words |
518 total filings indexed. 486 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000908259 |
| Ticker | OTLC |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Agoura Hills, California |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/OTLC (~200 tokens, structured JSON with cryptographic provenance)